06/22/2023 Imago Systems Submits Q-sub to FDA under Direction of Imago Board Member, Dr. Susan Alpert, M.D., Ph.D., for Its ICE Insight™ Software System (Imago ICE Insight™) for Cardiovascular Image Post-processing Read More
04/24/2023 Imago Systems, Inc., and Acculab Life Sciences, LLC, Announce Three-year Research Agreement in Cardiovascular Medicine Read More
03/23/2023 Thomas Ramsay, Imago Systems CEO, featured speaker at 2023 LSI Emerging Medtech Summit in Dana Point, California. Read More
03/21/2023 Imago Systems Selected as Innovator at LSI Emerging Medtech Summit Conference in California. Read More
03/10/2023 Imago Systems’ Visual Intelligence Positioned to Address Latest FDA Warnings about Dense Breast Cancer Detection Read More
03/09/2023 FDA Updates Mammography Regulations to Require Reporting of Breast Density Information and Enhance Facility Oversight Read More
01/27/2023 Imago Systems, Inc., Receives Clearance to Work with WCG for Acquiring Independent IRB)Assessments Faster Read More
09/17/2022 Imago Systems Selected to Present at Transcatheter Cardiovascular Therapeutics (TCT) Conference in Boston, MA Read More
